/ /

CLINICAL

Treating eczemas in skin of colorWhen it comes to treating atopic dermatitis in non-white racial ethnic groups, there are variations in prevalence, genetic factors and clinical presentation.
AD, skin microbes intertwinedAtopic dermatitis leads to Staphylococcus aureus colonization, one expert says.
Biologic class differentiatorsDermatology experts offer insight into differentiating factors among TNF-alpha inhibitors, the IL 12/23 antagonist, IL 17 inhibitors and an oral option that carry considerations for managing certain patients.
A peek at the pipelineThere is tremendous excitement surrounding IL-23 inhibitors for the treatment of psoriasis. Three are currently in the pipeline.
Paradoxical reactions to biologics provide insightParadoxical reactions to biologic treatments can provide clues into related conditions such as granulomatous diseases, genetic polymorphisms and latent infections, says an expert.
June Clinical Considerations for NPs, PAsThis month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
New systemic psoriasis treatments keep raising barBiologic inhibitors of IL-23 and IL-17 are commonly delivering responses of PASI 90 and above, says an expert.
Microbe imbalance fuels acneThe difference between acne and healthy skin is largely dependent on the balance of the skin microbiota, according to study results.
Intense pulsed light bridges eye care and aestheticsWhat is this age-defying modern technology that a young, nonmedical professional is applying to her face? It is a YAG laser combined with an intense pulse light (IPL).

Poll

View Results